These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6432996)

  • 1. Pharmacokinetics of nitroglycerin after parenteral and oral dosing in the rat.
    Fung HL; Ogata H; Kamiya A; Maier GA
    J Pharm Sci; 1984 Jul; 73(7):873-9. PubMed ID: 6432996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpretation of nitrate plasma concentrations. Effect of cardiac output on nitroglycerin pharmacokinetics in experimental animals.
    Fung HL; Blei A; Chong S
    Eur Heart J; 1988 Jan; 9 Suppl A():39-43. PubMed ID: 3137071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose dependent pharmacokinetics of nitroglycerin after multiple intravenous infusions in healthy volunteers.
    Noonan PK; Williams RL; Benet LZ
    J Pharmacokinet Biopharm; 1985 Apr; 13(2):143-57. PubMed ID: 3932639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and bioavailability of intravenous and topical nitroglycerin in the rhesus monkey: estimate of percutaneous first-pass metabolism.
    Wester RC; Noonan PK; Smeach S; Kosobud L
    J Pharm Sci; 1983 Jul; 72(7):745-8. PubMed ID: 6411893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bioavailability of oral nitroglycerin.
    Noonan PK; Benet LZ
    J Pharm Sci; 1986 Mar; 75(3):241-3. PubMed ID: 3084757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of the bioavailability of nitroglycerin from a transdermal therapeutic system (Nitroderm TTS).
    Imhof PR; Vuillemin T; Gérardin A; Racine A; Müller P; Follath F
    Eur J Clin Pharmacol; 1984; 27(1):7-12. PubMed ID: 6436032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac output is an apparent determinant of nitroglycerin pharmacokinetics in rats.
    Fung HL; Blei A; Chong S
    J Pharmacol Exp Ther; 1986 Dec; 239(3):701-5. PubMed ID: 3098960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the liver in the disposition of intravenous nitroglycerin in the rat.
    Blei AT; Gottstein J; Fung HL
    Biochem Pharmacol; 1984 Aug; 33(16):2681-6. PubMed ID: 6431989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rectal absorption of nitroglycerin in the rat: avoidance of first-pass metabolism as a function of rectal length exposure.
    Kamiya A; Ogata H; Fung HL
    J Pharm Sci; 1982 Jun; 71(6):621-4. PubMed ID: 6808113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitroglycerin pharmacokinetics after intravenous infusion in normal subjects.
    McNiff EF; Yacobi A; Young-Chang FM; Golden LH; Goldfarb A; Fung HL
    J Pharm Sci; 1981 Sep; 70(9):1054-8. PubMed ID: 6101155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of infusion administration set on the delivery rate and plasma concentration of nitroglycerin in dogs.
    McNiff EF; Lai CM; Look ZM; Yacobi A; Fung HL
    J Pharm Sci; 1985 Jul; 74(7):774-6. PubMed ID: 3928871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incomplete and delayed bioavailability of sublingual nitroglycerin.
    Noonan PK; Benet LZ
    Am J Cardiol; 1985 Jan; 55(1):184-7. PubMed ID: 3917598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of nitroglycerin in rats.
    Yap PS; Fung HL
    J Pharm Sci; 1978 Apr; 67(4):584-6. PubMed ID: 417170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of organic nitrates.
    Bogaert MG
    Clin Pharmacokinet; 1983; 8(5):410-21. PubMed ID: 6414751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent intravenous administration of a labeled tracer to determine the oral bioavailability of a drug exhibiting Michaelis-Menten metabolism.
    Rubin GM; Waschek JA; Pond SM; Effeney DJ; Tozer TN
    J Pharmacokinet Biopharm; 1987 Dec; 15(6):615-31. PubMed ID: 3450845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imipramine disposition in users of oral contraceptive steroids.
    Abernethy DR; Greenblatt DJ; Shader RI
    Clin Pharmacol Ther; 1984 Jun; 35(6):792-7. PubMed ID: 6734030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glyceryl-1-nitrate pharmacokinetics in healthy volunteers.
    Laufen H; Leitold M
    Br J Clin Pharmacol; 1987 Mar; 23(3):287-93. PubMed ID: 3105569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and bioavailability of diacetolol, the main metabolite of acebutolol.
    Flouvat B; Roux A; Chau NP; Viallet M; Andre-Fouet X; Woehrle R; Gregoire J
    Eur J Clin Pharmacol; 1981 Mar; 19(4):287-92. PubMed ID: 7286031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clevidipine: a review of its use in the management of acute hypertension.
    Deeks ED; Keating GM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of nitroglycerin in the beagle dog after intravenous and buccal administration.
    Ritschel WA; Shaaya AN; Tan HS
    Methods Find Exp Clin Pharmacol; 1985 Jun; 7(6):307-13. PubMed ID: 3932795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.